Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. (Q53116575)

11 May 2018

title

Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. (English)

1 reference

11 May 2018

author name string

H Wada

1

1 reference

11 May 2018

J Thachil

2

1 reference

11 May 2018

M Di Nisio

3

1 reference

11 May 2018

P Mathew

4

1 reference

11 May 2018

S Kurosawa

5

1 reference

11 May 2018

S Gando

6

1 reference

11 May 2018

H K Kim

7

1 reference

11 May 2018

J D Nielsen

8

1 reference

11 May 2018

C-E Dempfle

9

1 reference

11 May 2018

M Levi

10

1 reference

11 May 2018

C-H Toh

11

1 reference

11 May 2018

The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis

12

1 reference

11 May 2018

publication date

4 February 2013

1 reference

11 May 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

11 May 2018

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

cites work

1 reference

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

21 January 2018

1 reference

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

21 January 2018

1 reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria

21 January 2018

1 reference

Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation.

21 January 2018

1 reference

Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response

21 January 2018

1 reference

Disseminated intravascular coagulation: old disease, new hope

21 January 2018

1 reference

The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview

21 January 2018

1 reference

Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.

21 January 2018

1 reference

21 January 2018

1 reference

Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries

21 January 2018

1 reference

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

21 January 2018

1 reference

Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases

21 January 2018

1 reference

Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation.

21 January 2018

1 reference

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

21 January 2018

1 reference

Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

21 January 2018

1 reference

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

Coagulation abnormalities in critically ill patients

21 January 2018

1 reference

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin

21 January 2018

1 reference

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

21 January 2018

1 reference

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

21 January 2018

1 reference

Prevention and treatment of major blood loss

21 January 2018

1 reference

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

21 January 2018

1 reference

All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia

21 January 2018

1 reference

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12155

1 reference

11 May 2018

1 reference

11 May 2018